We were proud to publish an article in the specialist magazine “Swiss Pharma”, issue 1/22. The topic of this issue was modern qualification with best practice examples.
You can find our article on page 50 of the magazine. The link to the issue is here.
Or read the article directly on our website:
More capacity for the next steps: With the expansion of our warehouse space by approximately 170 m², we at Canexis Pharma are creating
The existing Canexis portfolio includes cannabidiol Ph. Eur. as well as THC- and CBD-containing extracts and distillates. Discussions with partner companies indicate that...
Initial results from the ongoing stability study show a stable quality profile for THC extract and THC distillate. The currently available data support this.
